Former Exec Convicted Of Medtronic Insider Trading Scheme

By Emilie Ruscoe · February 21, 2024, 9:30 PM EST

A Minneapolis man who tipped off a friend about his employer's secret negotiations on a $1.6 billion acquisition deal with medical device company Medtronic has been convicted of securities fraud and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Securities and Exchange Commission v. Tavlin et al

Case Number

Court

Minnesota

Nature of Suit

Securities/Commodities

Date Filed

July 06, 2022

Case Title

USA v. Tavlin et al

Case Number

Court

Minnesota

Nature of Suit

Date Filed

June 30, 2022

Recent Articles By Emilie

October 30, 2024
LA Times Owner Faces Investor Suit Over Drug Co.'s Woes
October 28, 2024
Moderna Brass Hit With Investor Suit Over RSV Shot Claims
October 22, 2024
Pharma Co. Verrica Faces Derivative Suit Over FDA Inspection
October 16, 2024
Pharma Co. Contractor Settles SEC Insider Trading Claim
September 24, 2024
Biotech RenovaCare Investors Seek OK Of $2M Deal
September 03, 2024
Teva Investors Get Go-Ahead To Resume Kickbacks Class Suit
August 02, 2024
Health Tech Co. Beats Investor Data Platform Fraud Claim
July 15, 2024
Ex-Pfizer Worker Seeks No Time For Paxlovid Insider Trading
May 20, 2024
Teladoc Faces Suit Over Mental Health Platform's Losses
May 14, 2024
Vein Tech Maker Faces Investor Suit Over DOJ Kickback Probe